Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
This study aims to evaluate efficacy and acceptability of the Chinese language version of MoodGYM as a therapeutic intervention in treating symptoms of depression in community dwelling Chinese Americans in the Boston area.
Hypothesis 1: Participants enrolled in MoodGYM will show a significant decrease in depressive symptoms after completion of the 5 modules.
Hypothesis 2: Participants enrolled in MoodGYM will show significantly improved dysfunctional thinking.
Hypothesis 3: Participants enrolled in MoodGym will rate this program as culturally acceptable.
|Study Design:||Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
|Official Title:||Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans|
- Change in Center for Epidemiologic Studies Depression Scale (CES-D) [ Time Frame: Weeks 0, 6 (pre/post) ]The CES-D scale is a short self-report scale designed to measure depressive symptomatology in the general population. Each of the 20 items in this instrument is assigned one value of 0, 1, 2 or 3. High scores on the CES-D indicate high levels of distress.
|Study Start Date:||September 2014|
|Study Completion Date:||November 2016|
|Primary Completion Date:||December 2015 (Final data collection date for primary outcome measure)|
This study is a single-arm intervnetion. All subjects will be assigned to receive six weeks of online CBT through MoodGYM.
MoodGYM, a publicly-available online CBT program developed by the Centre for Mental Health Research at The Australian National University has been shown by multiple studies to be effective in reducing symptoms of depression. MoodGYM consists of five interactive modules. Participants will be asked to complete one module each week and progress through the program sequentially.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01851967
|United States, Massachusetts|
|Massachusetts General Hospital Depression Clinical and Research Program|
|Boston, Massachusetts, United States, 02114|